HUP0200189A2 - Nikotintartalmú transzdermális rendszer - Google Patents

Nikotintartalmú transzdermális rendszer

Info

Publication number
HUP0200189A2
HUP0200189A2 HU0200189A HUP0200189A HUP0200189A2 HU P0200189 A2 HUP0200189 A2 HU P0200189A2 HU 0200189 A HU0200189 A HU 0200189A HU P0200189 A HUP0200189 A HU P0200189A HU P0200189 A2 HUP0200189 A2 HU P0200189A2
Authority
HU
Hungary
Prior art keywords
nicotine
therapeutic system
transdermal therapeutic
layer
ttss
Prior art date
Application number
HU0200189A
Other languages
English (en)
Inventor
Stefan Bracht
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of HUP0200189A2 publication Critical patent/HUP0200189A2/hu
Publication of HUP0200189A3 publication Critical patent/HUP0200189A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány szerinti transzdermális gyógyászati rendszer (TTS); egyhátoldalréteggel, legalább egy nikotintartalmú réteggel vagy sávval,amely tartósan tapadó tulajdonságú is lehet, valamint egy újraeltávolítható védőréteggel, amely legalább egy, valamely mentafajtábólnyert illóolajat vagy monoterpén ketont tartalmaz, amely ezekben azillóolajakban előfordul. A találmány tárgya továbbá eljárás az ilyenTTS-ek kellemetlen szagának lefedésére, valamint a szagot javítóanyagok felhasználá- sára. Ó
HU0200189A 1999-03-26 2000-03-21 Transdermal therapeutic system with nicotine HUP0200189A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19913732A DE19913732A1 (de) 1999-03-26 1999-03-26 Nikotin-TTS mit einem Zusatz von Monoterpenketonen

Publications (2)

Publication Number Publication Date
HUP0200189A2 true HUP0200189A2 (hu) 2002-05-29
HUP0200189A3 HUP0200189A3 (en) 2011-02-28

Family

ID=7902491

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200189A HUP0200189A3 (en) 1999-03-26 2000-03-21 Transdermal therapeutic system with nicotine

Country Status (23)

Country Link
US (1) US7029692B1 (hu)
EP (1) EP1164996B1 (hu)
JP (1) JP4750282B2 (hu)
KR (1) KR100597802B1 (hu)
CN (1) CN1199623C (hu)
AR (1) AR027485A1 (hu)
AT (1) ATE252356T1 (hu)
AU (1) AU769656B2 (hu)
BR (1) BR0010515A (hu)
CA (1) CA2367615C (hu)
CZ (1) CZ300409B6 (hu)
DE (2) DE19913732A1 (hu)
DK (1) DK1164996T3 (hu)
ES (1) ES2211523T3 (hu)
HU (1) HUP0200189A3 (hu)
IL (1) IL145502A0 (hu)
NZ (1) NZ514423A (hu)
PT (1) PT1164996E (hu)
RU (1) RU2228740C2 (hu)
TR (1) TR200102605T2 (hu)
TW (1) TWI227666B (hu)
WO (1) WO2000057824A1 (hu)
ZA (1) ZA200107864B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
ATE355854T1 (de) * 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
JP5619337B2 (ja) * 2003-10-10 2014-11-05 フェリング ビー．ブイ． 皮膚残渣を最小限に抑えるための経皮的医薬製剤
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
EP1774964B1 (en) * 2005-10-13 2014-08-06 Nitto Denko Corporation Nicotine transdermal preparation and production method thereof
CN101426475A (zh) * 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
CN101264277B (zh) * 2008-04-16 2012-09-26 冯冲 一种控烟戒烟复方精油
KR101831463B1 (ko) * 2010-03-26 2018-02-22 필립모리스 프로덕츠 에스.에이. 비흡연성 담배 제품의 소비 시 감각 자극의 억제
JP5730355B2 (ja) * 2013-07-24 2015-06-10 学校法人近畿大学 Ｃｙｐ２ａ１３阻害剤
JP6888974B2 (ja) * 2016-01-27 2021-06-18 学校法人近畿大学 Ｃｙｐ２ａ１３阻害活性を有する化合物及びｃｙｐ２ａ１３阻害剤
US20190083386A1 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Methods and formulations for transdermal administration of buffering agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3559655A (en) * 1969-02-25 1971-02-02 Sutton Res Corp Oxidized cellulose substitute smoking material and method of making same
US4039653A (en) * 1974-01-23 1977-08-02 Defoney, Brenman, Mayes & Baron Long-acting articles for oral delivery and process
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
JPH01157921A (ja) * 1987-12-15 1989-06-21 Tsumura & Co 二重盲検試験用製剤の製造方法
JPH01290608A (ja) * 1988-05-18 1989-11-22 Sunstar Inc 殺菌剤組成物
ATE101511T1 (de) * 1988-08-02 1994-03-15 Ciba Geigy Ag Mehrschichtiges pflaster.
JP2905210B2 (ja) * 1989-01-23 1999-06-14 フロイント産業株式会社 経皮、経粘膜吸収促進剤および経皮、経粘膜製剤
JPH0748190B2 (ja) * 1990-01-22 1995-05-24 株式会社東芝 キャッシュメモリ内蔵マイクロプロセッサ
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
JPH06181972A (ja) * 1992-12-18 1994-07-05 Kanebo Ltd 煙草臭消臭剤
US5520924A (en) * 1993-07-09 1996-05-28 Mizu Systems Corporation Methods and articles for administering drug to the oral cavity
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
JPH07133490A (ja) * 1993-11-10 1995-05-23 Pola Chem Ind Inc 消臭剤
AU2703795A (en) * 1994-06-23 1996-01-19 Procter & Gamble Company, The Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
JPH09110680A (ja) * 1995-10-19 1997-04-28 Yuutoku Yakuhin Kogyo Kk 皮膚炎治療貼付剤
JPH10130118A (ja) * 1996-10-25 1998-05-19 Lion Corp 外用剤組成物
JPH10306030A (ja) * 1997-05-07 1998-11-17 Taisho Pharmaceut Co Ltd 外用剤組成物

Also Published As

Publication number Publication date
BR0010515A (pt) 2003-07-22
WO2000057824A1 (de) 2000-10-05
EP1164996A1 (de) 2002-01-02
JP4750282B2 (ja) 2011-08-17
HUP0200189A3 (en) 2011-02-28
ATE252356T1 (de) 2003-11-15
US7029692B1 (en) 2006-04-18
CN1345213A (zh) 2002-04-17
CZ300409B6 (cs) 2009-05-13
IL145502A0 (en) 2002-06-30
DE19913732A1 (de) 2000-09-28
PT1164996E (pt) 2004-03-31
AU3813400A (en) 2000-10-16
TR200102605T2 (tr) 2002-01-21
JP2002540125A (ja) 2002-11-26
CN1199623C (zh) 2005-05-04
CA2367615C (en) 2009-10-13
CZ20013457A3 (cs) 2002-03-13
EP1164996B1 (de) 2003-10-22
AU769656B2 (en) 2004-01-29
DE50004156D1 (de) 2003-11-27
ES2211523T3 (es) 2004-07-16
CA2367615A1 (en) 2000-10-05
AR027485A1 (es) 2003-04-02
ZA200107864B (en) 2002-11-27
RU2228740C2 (ru) 2004-05-20
DK1164996T3 (da) 2004-02-16
PL351313A1 (en) 2003-04-07
TWI227666B (en) 2005-02-11
NZ514423A (en) 2003-08-29
KR20010112366A (ko) 2001-12-20
KR100597802B1 (ko) 2006-07-10

Similar Documents

Publication Publication Date Title
HUP0200189A2 (hu) Nikotintartalmú transzdermális rendszer
EE200300095A (et) Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega
HUP0103883A2 (hu) Új, késleltetett felszabadulású, orális készítmények
CY1105716T1 (el) Διαδερμικο εμπλαστρο σταθερο εναντι uv
WO2006029740A3 (de) Transdermales therapeutisches system mit einer haftschicht, verfahren zum silikonisieren einer rückschicht des systems und verwendung der rückschicht
DE69717862T2 (de) Pharmazeutisches trägermittel, geeignet zur applikation pharmazeutischer verbindungen auf mucosale öberflächen
HUP0401590A2 (hu) Eljárások allogén sziget átültetés védelmére oldható CTLA4 mutáns molekulák alkalmazásával
DE60039900D1 (de) System zur domänenauswahl sowie verfahren
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
ATE449599T1 (de) Zusammensetzung zur transdermalen verabreichung von fentanyl
HUP0302881A2 (hu) Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények
DE60126795D1 (de) Verfahren und Kit zur Bestimmung der geographischen bzw. populationsmässigen Herkunft von Menschen
ATE339521T1 (de) Verfahren zur bestimmung der expression des dihydropyrimidindehydrogenasegens
WO2005082428A3 (de) Pflaster mit reduzierter hautirritation
IL198745A0 (en) Transdermal therapeutic system comprising ion fair micro-reservoirs
HUP0104413A2 (hu) Ascomycineket tartalmazó helyi készítmények
HUP0303311A2 (hu) Hatóanyagként nikotint tartalmazó nagy flexibilitású transzdermális terápiás rendszer
HUP0104728A2 (hu) Átlátszó transzdermális nikotinadagoló eszköz
SE9603725D0 (sv) New teatment
ATE485818T1 (de) Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
HUP0204448A2 (en) Trnasdermal therapeutic system for the delivery of lerisetron
DE60136916D1 (de) Zusammensetzung und verfahren zur verhütung und/oder behandlung von der pii allergien
DE69809284D1 (de) Immunomodulator mit anti-mikrobakteriellen und anti-mykobakteriellen eigenschaften, verfahren zu seiner herstellung und pharmazeutische zusammensetzungen zur behandlung von mykobakteriosen sowie von chronischen und nicht-spezifischen lungenzuständen, sexuell übertragbaren krankheiten und den daraus resultierenden immunschwächen
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished